Holen Sie sich die Stockscreener-App
26.99
1.60%
-0.44
Handel nachbörslich:
27.47
0.48
+1.78%
Schlusskurs vom Vortag:
$27.43
Offen:
$27.45
24-Stunden-Volumen:
1.34M
Relative Volume:
0.83
Marktkapitalisierung:
$2.33B
Einnahmen:
$1.13B
Nettoeinkommen (Verlust:
$62.75M
KGV:
42.84
EPS:
0.63
Netto-Cashflow:
$170.92M
1W Leistung:
+4.86%
1M Leistung:
+9.18%
6M Leistung:
+13.50%
1J Leistung:
+47.89%
1-Tages-Spanne:
$26.93
$27.86
1-Wochen-Bereich:
$25.80
$28.49
52-Wochen-Spanne:
$17.79
$28.49
Progyny Inc Stock (PGNY) Company Profile
Firmenname
Progyny Inc
Sektor
Branche
Telefon
212-888-3124
Adresse
1359 BROADWAY, NEW YORK, NY
Vergleichen Sie PGNY mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
PGNY
Progyny Inc
|
26.99 | 2.36B | 1.13B | 62.75M | 170.92M | 0.63 |
|
UNH
Unitedhealth Group Inc
|
343.98 | 314.19B | 435.16B | 18.37B | 17.37B | 19.16 |
|
CVS
Cvs Health Corp
|
80.30 | 102.32B | 393.94B | 428.00M | 6.29B | 0.3826 |
|
ELV
Elevance Health Inc
|
372.83 | 83.29B | 194.82B | 5.53B | 3.77B | 24.45 |
|
CI
Cigna Group
|
278.95 | 75.84B | 268.22B | 6.55B | 7.44B | 22.67 |
|
HUM
Humana Inc
|
276.85 | 33.38B | 126.36B | 1.30B | 1.55B | 10.67 |
Progyny Inc Stock (PGNY) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-12-09 | Eingeleitet | Barclays | Overweight |
| 2025-11-12 | Hochstufung | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2025-07-08 | Hochstufung | Leerink Partners | Market Perform → Outperform |
| 2024-12-02 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2024-11-13 | Herabstufung | Truist | Buy → Hold |
| 2024-09-19 | Herabstufung | JMP Securities | Mkt Outperform → Mkt Perform |
| 2024-08-07 | Herabstufung | BTIG Research | Buy → Neutral |
| 2024-08-07 | Herabstufung | Canaccord Genuity | Buy → Hold |
| 2024-08-07 | Herabstufung | Leerink Partners | Outperform → Market Perform |
| 2024-07-16 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2024-05-10 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2024-02-26 | Eingeleitet | Leerink Partners | Outperform |
| 2024-01-03 | Eingeleitet | Barclays | Overweight |
| 2023-09-27 | Eingeleitet | Canaccord Genuity | Buy |
| 2023-05-22 | Eingeleitet | BTIG Research | Buy |
| 2023-04-21 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2023-01-05 | Herabstufung | SVB Leerink | Outperform → Mkt Perform |
| 2022-09-16 | Eingeleitet | KeyBanc Capital Markets | Overweight |
| 2022-09-07 | Eingeleitet | Truist | Buy |
| 2021-12-02 | Eingeleitet | Jefferies | Buy |
| 2021-11-22 | Herabstufung | Citigroup | Buy → Neutral |
| 2021-09-30 | Eingeleitet | Berenberg | Buy |
| 2021-08-12 | Eingeleitet | Barclays | Overweight |
| 2021-06-02 | Herabstufung | Guggenheim | Buy → Neutral |
| 2021-04-29 | Fortgesetzt | JP Morgan | Overweight |
| 2021-03-10 | Hochstufung | BofA Securities | Neutral → Buy |
| 2020-07-01 | Eingeleitet | SVB Leerink | Outperform |
| 2020-06-02 | Eingeleitet | Guggenheim | Buy |
| 2019-11-19 | Eingeleitet | Citigroup | Buy |
| 2019-11-19 | Eingeleitet | Goldman | Buy |
| 2019-11-19 | Eingeleitet | JP Morgan | Overweight |
| 2019-11-19 | Eingeleitet | Piper Jaffray | Overweight |
| 2019-11-19 | Eingeleitet | SVB Leerink | Outperform |
Alle ansehen
Progyny Inc Aktie (PGNY) Neueste Nachrichten
Progyny, Inc. (PGNY) Soars to 52-Week High, Time to Cash Out? - sharewise.com
Progyny stock hits 52-week high at 27.84 USD By Investing.com - Investing.com Nigeria
Why Progyny Inc. stock is seen as undervaluedGap Up & Low Drawdown Investment Ideas - ulpravda.ru
Progyny (NASDAQ:PGNY) stock performs better than its underlying earnings growth over last year - Sahm
PGNY: Keybanc Maintains Overweight Rating and Raises Price Targe - GuruFocus
Progyny (PGNY) Stock Hits New High: Keybanc Raises Target to $32News and Statistics - IndexBox
Why Progyny Inc. stock remains a top recommendationRisk Management & Low Risk Growth Stock Ideas - ulpravda.ru
Progyny (PGNY) Stock Is Up, What You Need To Know - Finviz
Truist Securities upgrades Progyny stock rating to Buy on improved outlook By Investing.com - Investing.com South Africa
Truist Securities upgrades Progyny stock rating to Buy on improved outlook - Investing.com Nigeria
How Progyny Inc. stock trades during market volatilityLayoff News & Safe Entry Point Identification - ulpravda.ru
Why Progyny’s Stock Is Quietly Breaking Higher - TipRanks
Liquidity Mapping Around (PGNY) Price Events - Stock Traders Daily
Progyny, Inc. (PGNY) Stock Analysis: Investor Outlook With A Promising 10% Upside - DirectorsTalk Interviews
The Truth About Progyny Inc: Is This Fertility Stock the Next Silent Millionaire Maker? - AD HOC NEWS
Progyny (NASDAQ:PGNY) Rating Increased to Strong-Buy at Zacks Research - MarketBeat
Progyny (NASDAQ:PGNY) Stock Rating Upgraded by Wall Street Zen - MarketBeat
2 Reasons PGNY is Risky and 1 Stock to Buy Instead - Yahoo Finance
Fort Washington Investment Advisors Inc. OH Has $35.65 Million Stake in Progyny, Inc. $PGNY - MarketBeat
Progyny rises on guidance update - MSN
Pacer Advisors Inc. Has $8.29 Million Stock Holdings in Progyny, Inc. $PGNY - MarketBeat
Progyny Earnings Notes - Trefis
PGNY (Progyny) Retained Earnings : $190 Mil (As of Sep. 2025) - GuruFocus
PGNY (Progyny) Total Stockholders Equity : $560 Mil (As of Sep. 2025) - GuruFocus
PGNY (Progyny) 3-Year EPS without NRI Growth Rate : 35.40% (As of Sep. 2025) - GuruFocus
Price-Driven Insight from (PGNY) for Rule-Based Strategy - Stock Traders Daily
Progyny (PGNY): Reassessing Valuation After a Recent Share Price Pullback - Yahoo Finance
Progyny, Inc. (PGNY) hits fresh high: Is there still room to run? - MSN
Progyny, Inc. (PGNY) Hits Fresh High: Is There Still Room to Run? - sharewise.com
Progyny (NASDAQ:PGNY) Hits New 52-Week HighHere's What Happened - MarketBeat
Progyny stock hits 52-week high at $27.52 By Investing.com - Investing.com Canada
Progyny stock hits 52-week high at $27.52 - Investing.com
Leadership Reshuffle Without a Successor Might Change The Case For Investing In Progyny (PGNY) - simplywall.st
Wall Street Zen Downgrades Progyny (NASDAQ:PGNY) to Hold - MarketBeat
Progyny, Inc. (NASDAQ:PGNY) Given Consensus Rating of "Moderate Buy" by Brokerages - MarketBeat
Has Progyny’s 85.7% Surge in 2025 Already Priced In Its Growth Story? - Yahoo Finance
Interesting PGNY Put And Call Options For August 2026 - Nasdaq
Aug Levels: What sentiment indicators say about Progyny Inc. stockTrade Signal Summary & Stock Market Timing Techniques - DonanımHaber
Is Progyny Inc. stock in correction or buying zone2025 Market WrapUp & AI Enhanced Trading Signals - Улправда
How sustainable is Progyny Inc. stock dividend payoutWeekly Trading Summary & Technical Pattern Alert System - DonanımHaber
Is Progyny Inc. stock a smart buy before Fed meetingJuly 2025 Snapshot & Safe Swing Trade Setup Alerts - Улправда
Progyny President’s Employment to End December 2025 - The Globe and Mail
Progyny, Inc. Announces Departure of President Michael Sturmer - TradingView — Track All Markets
Progyny (PGNY) President to exit role, stay on as paid consultant - Stock Titan
Progyny, Inc. Announces Cessation of Michael Sturmer as President, Effective as of December 31, 2025 - marketscreener.com
3 Healthcare Stocks We're Skeptical Of - Finviz
Progyny CFO Mark S. Livingston Sells 459 Shares - TradingView — Track All Markets
CFO Livingston Sells 459 ($11.7K) Of Progyny Inc [PGNY] - TradingView — Track All Markets
Progyny (PGNY) CFO Mark S. Livingston reports 459-share sale in 10b5-1 plan - Stock Titan
Progyny (PGNY) Upgraded to Buy: Here's What You Should Know - sharewise.com
The Technical Signals Behind (PGNY) That Institutions Follow - Stock Traders Daily
Finanzdaten der Progyny Inc-Aktie (PGNY)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.81%
4.91%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):